Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer.
Garralda E, Sukari A, Lakhani NJ, Patnaik A, Lou Y, Im SA, Golan T, Geva R, Wermke M, de Miguel M, Palcza J, Jha S, Chaney M, Abraham AK, Healy J, Falchook GS. Garralda E, et al. Among authors: healy j. ESMO Open. 2022 Dec;7(6):100639. doi: 10.1016/j.esmoop.2022.100639. Epub 2022 Dec 6. ESMO Open. 2022. PMID: 36493599 Free PMC article.
SARS-CoV-2 infection in general practice in Ireland: a seroprevalence study.
O'Callaghan ME, Ryan E, Walsh C, Hayes P, Casey M, O'Dwyer P, Culhane A, Duncan JW, Harrold P, Healy J, Kerin E, Kelly E, Hanrahan C, Lane GP, Lynch B, Meaney P, O'Connell B, Galvin J, Kennedy N, Burke P, O'Connell NH, Dunne CP, Glynn LG. O'Callaghan ME, et al. Among authors: healy j. BJGP Open. 2021 Aug 24;5(4):BJGPO.2021.0038. doi: 10.3399/BJGPO.2021.0038. Print 2021 Aug. BJGP Open. 2021. PMID: 34006528 Free PMC article.
Accuracy of energy and nutrient intake estimation versus observed intake using four technology-assisted dietary assessment methods: a randomized crossover feeding study.
Whitton C, Collins CE, Mullan BA, Rollo ME, Dhaliwal SS, Norman R, Boushey CJ, Delp EJ, Zhu F, McCaffrey TA, Kirkpatrick SI, Pollard CM, Healy JD, Hassan A, Garg S, Atyeo P, Mukhtar SA, Kerr DA. Whitton C, et al. Among authors: healy jd. Am J Clin Nutr. 2024 May 4:S0002-9165(24)00456-8. doi: 10.1016/j.ajcnut.2024.04.030. Online ahead of print. Am J Clin Nutr. 2024. PMID: 38710447
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products.
Stewart MD, Kalos M, Coutinho V, Better M, Jazayeri J, Yohrling J, Jadlowsky J, Fuchs M, Gidwani S, Goessl C, Hanley PJ, Healy J, Liu W, McKelvey BA, Pearce L, Pilon-Thomas S, Andrews HS, Veldman M, Vong J, Weinbach SP, Allen JD. Stewart MD, et al. Among authors: healy j. Cytotherapy. 2024 Mar 16:S1465-3249(24)00097-5. doi: 10.1016/j.jcyt.2024.03.009. Online ahead of print. Cytotherapy. 2024. PMID: 38583170 Free article.
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M, Tran TT, Cowey CL, Pecora A, Shaheen M, Segar J, Medina T, Atkinson V, Gibney GT, Luke JJ, Thomas S, Buchbinder EI, Healy JA, Huang M, Morrissey M, Feldman I, Sehgal V, Robert-Tissot C, Hou P, Zhu L, Brown M, Aanur P, Meehan RS, Zaks T. Weber JS, et al. Among authors: healy ja. Lancet. 2024 Feb 17;403(10427):632-644. doi: 10.1016/S0140-6736(23)02268-7. Epub 2024 Jan 18. Lancet. 2024. PMID: 38246194 Clinical Trial.
771 results